2024 Recommendations on the Optimal Use of Lipid-Lowering Therapy in Established Atherosclerotic Cardiovascular Disease and Following Acute Coronary Syndromes: A Position Paper of the International Lipid Expert Panel (ILEP).

Banach M, Reiner Ž, Surma S, Bajraktari G, Bielecka-Dabrowa A, Bunc M, Bytyçi I, Ceska R, Cicero AFG, Dudek D, Dyrbuś K, Fedacko J, Fras Z, Gaita D, Gavish D, Gierlotka M, Gil R, Gouni-Berthold I, Jankowski P, Járai Z, Jóźwiak J, Katsiki N, Latkovskis G, Magda SL, Margetic E, Margoczy R, Mitchenko O, Durak-Nalbantic A, Ostadal P, Paragh G, Petrulioniene Z, Paneni F, Pećin I, Pella D, Postadzhiyan A, Stoian AP, Trbusic M, Udroiu CA, Viigimaa M, Vinereanu D, Vlachopoulos C, Vrablik M, Vulic D, Penson PE, International Lipid Expert Panel (ILEP)

Open source

DOI
10.1007/s40265-024-02105-5
Published
2024 Dec
Container
Drugs
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1007/s40265-024-02105-5,
  title = {2024 Recommendations on the Optimal Use of Lipid-Lowering Therapy in Established Atherosclerotic Cardiovascular Disease and Following Acute Coronary Syndromes: A Position Paper of the International Lipid Expert Panel (ILEP).},
  author = {Banach M and Reiner Ž and Surma S and Bajraktari G and Bielecka-Dabrowa A and Bunc M and Bytyçi I and Ceska R and Cicero AFG and Dudek D and Dyrbuś K and Fedacko J and Fras Z and Gaita D and Gavish D and Gierlotka M and Gil R and Gouni-Berthold I and Jankowski P and Járai Z and Jóźwiak J and Katsiki N and Latkovskis G and Magda SL and Margetic E and Margoczy R and Mitchenko O and Durak-Nalbantic A and Ostadal P and Paragh G and Petrulioniene Z and Paneni F and Pećin I and Pella D and Postadzhiyan A and Stoian AP and Trbusic M and Udroiu CA and Viigimaa M and Vinereanu D and Vlachopoulos C and Vrablik M and Vulic D and Penson PE and International Lipid Expert Panel (ILEP)},
  year = {2024},
  journal = {Drugs},
  doi = {10.1007/s40265-024-02105-5},
  url = {https://doi.org/10.1007/s40265-024-02105-5}
}

RIS

TY  - JOUR
TI  - 2024 Recommendations on the Optimal Use of Lipid-Lowering Therapy in Established Atherosclerotic Cardiovascular Disease and Following Acute Coronary Syndromes: A Position Paper of the International Lipid Expert Panel (ILEP).
AU  - Banach M
AU  - Reiner Ž
AU  - Surma S
AU  - Bajraktari G
AU  - Bielecka-Dabrowa A
AU  - Bunc M
AU  - Bytyçi I
AU  - Ceska R
AU  - Cicero AFG
AU  - Dudek D
AU  - Dyrbuś K
AU  - Fedacko J
AU  - Fras Z
AU  - Gaita D
AU  - Gavish D
AU  - Gierlotka M
AU  - Gil R
AU  - Gouni-Berthold I
AU  - Jankowski P
AU  - Járai Z
AU  - Jóźwiak J
AU  - Katsiki N
AU  - Latkovskis G
AU  - Magda SL
AU  - Margetic E
AU  - Margoczy R
AU  - Mitchenko O
AU  - Durak-Nalbantic A
AU  - Ostadal P
AU  - Paragh G
AU  - Petrulioniene Z
AU  - Paneni F
AU  - Pećin I
AU  - Pella D
AU  - Postadzhiyan A
AU  - Stoian AP
AU  - Trbusic M
AU  - Udroiu CA
AU  - Viigimaa M
AU  - Vinereanu D
AU  - Vlachopoulos C
AU  - Vrablik M
AU  - Vulic D
AU  - Penson PE
AU  - International Lipid Expert Panel (ILEP)
PY  - 2024
JO  - Drugs
DO  - 10.1007/s40265-024-02105-5
UR  - https://doi.org/10.1007/s40265-024-02105-5
ER  -

APA

M, B., Ž, R., S, S., G, B., A, B., M, B., I, B., R, C., AFG, C., D, D., K, D., J, F., Z, F., D, G., D, G., M, G., R, G., I, G., P, J., Z, J., J, J., N, K., G, L., SL, M., E, M., R, M., O, M., A, D., P, O., G, P., Z, P., F, P., I, P., D, P., A, P., AP, S., M, T., CA, U., M, V., D, V., C, V., M, V., D, V., PE, P., & (ILEP), I. L. E. P. (2024). 2024 Recommendations on the Optimal Use of Lipid-Lowering Therapy in Established Atherosclerotic Cardiovascular Disease and Following Acute Coronary Syndromes: A Position Paper of the International Lipid Expert Panel (ILEP).. Drugs. https://doi.org/10.1007/s40265-024-02105-5

Source records